نتایج جستجو برای: gvhd مزمن

تعداد نتایج: 14120  

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1991
H Sakamoto J Michaelson W K Jones A K Bhan S Abhyankar M Silverstein D E Golan S J Burakoff J L Ferrara

Graft-versus-host disease (GVHD) is known to cause profound dysregulation of the immune system, although its effector mechanisms are poorly understood. We now describe an effector lymphocyte of unusual phenotype in the skin of mice with GVHD. This cell is of donor origin and expresses several T-cell surface proteins including Thy-1, CD2, and CD4 but does not express CD8, CD3, NK1.1, or macropha...

Journal: :Annals of dermatology 2009
Hyo Sang Ahn Hyun Jeong Park Jun Young Lee Baik Kee Cho

Graft versus host disease (GVHD) has traditionally been divided into acute GVHD and chronic GVHD based on the period it occurs after transplantation. Chronic cutaneous GVHD has traditionally been classified into the lichenoid and scleroderma-like forms. However, unusual clinical forms have been reported such as dermatomyositis, lupus erythematosus and exfoliative dermatitis. A 35-year-old woman...

2005
John R. Wingard Steven Piantadosi Georgia B. Vogelsang Evan R. Farmer Douglas A. Jabs L. Stefan Levin William E. Beschorner Richard A. Cahill Dawn F. Miller Dean Harrison Rein Saral George W. Santos

Chronic graft-v-host disease (chronic GVHD) is a frequent cause of late morbidity and death after bone marrow transplantation (BMT). The actuarial survival after onset of chronic GVHD in 85 patients was 42% (95%Cl = 29%. 54%) at 1 0 years. Baseline characteristics present at the onset of chronic GVHD (before therapy) in 85 patients were reviewed to determine which were risk factors for death. I...

Journal: :Blood 2004
Marjan Ertault-Daneshpouy Christophe Leboeuf Marc Lemann Fatiha Bouhidel Lionel Ades Eliane Gluckman Gérard Socié Anne Janin

In an experimental model we demonstrated that endothelial cells of all organs are targets of the alloimmune reaction. Here, in 68 digestive biopsies, we found endothelial lesions by immunohistochemistry and ultrastructure in patients with severe acute graft-versus-host disease (GVHD). In contrast, no such endothelial cell alterations were found either in patients without GVHD or in nongrafted c...

Journal: :Blood 2013
Effie W Petersdorf

Acute graft-versus-host disease (GVHD) afflicts as much as 80% of all patients who receive an unrelated donor hematopoietic cell transplant (HCT) for the treatment of blood disorders, even with optimal donor HLA matching and use of prophylactic immunosuppressive agents. Of patients who develop acute GVHD, many are at risk for chronic GVHD and bear the burden of considerable morbidity and lowere...

Journal: :Current hematologic malignancy reports 2014
Frédéric Baron Stéphanie Humblet-Baron Grégory Ehx Sophie Servais Muriel Hannon Ludovic Belle Chantal Lechanteur Alexandra Briquet Olivier Giet Etienne Baudoux Evelyne Willems Yves Beguin

Graft-versus-host disease (GVHD) remains a major limitation of allogeneic hematopoietic cell transplantation (allo-HCT). Despite major advances in the understanding of GVHD pathogenesis, standard GVHD prophylaxis regimens continue to be based on the combination of a calcineurin inhibitor with an antimetabolite, while first line treatments still rely on high-dose corticosteroids. Further, no sec...

2006
Howard M. Shulman David Kleiner Stephanie J. Lee Thomas Morton Steven Z. Pavletic Evan Farmer J. Margaret Moresi Joel Greenson Anne Janin Paul J. Martin George McDonald Mary E. D. Flowers Maria Turner Jane Atkinson Jay Lefkowitch M. Kay Washington Victor G. Prieto Stella K. Kim Zsolt Argenyi A. Hafeez Diwan Asif Rashid Kim Hiatt Dan Couriel Kirk Schultz Sharon Hymes Georgia B. Vogelsang

This consensus document provides an update for pathologists and clinicians about the interpretation of biopsy results and use of this information in the management of hematopoietic cell transplantation patients. Optimal sampling and tissue preparation are discussed. Minimal criteria for the diagnosis of graft-versus-host disease (GVHD) are proposed, together with specific requirements for the d...

Journal: :Journal of Pediatric and Adolescent Gynecology 2023

BackgroundVulvovaginal graft-versus-host disease (GVHD) is an underdiagnosed and poorly recognized complication of HSCT1,2. We aim to present hysteroscopic management cervicovaginal dense adhesions developed as a long-term sequelae vulvovaginal GVHD in 16-years-old girl who has Diamond-Blackfan Anemia. The institutional review board approval was obtained.CaseA presented with pelvic pain for las...

Journal: :Malaysian journal of pharmacy 2022

Background: Cyclosporine (CSA) is required as a prophylaxis of graft-versus-host disease (GVHD) following allogeneic haematopoietic stem cell transplant (HSCT). However, subtherapeutic CSA concentration will increase the incidence acute GVHD which one major concerns. Objective: This study aims to identify patients who achieved therapeutic initial level with standard intravenous dose 1.5 mg/kg B...

Journal: :Journal of Investigative Dermatology 2023

Patients who receive stem cell transplantation (SCT) can develop cutaneous eruptions with systemic involvement such as graft versus host disease (GVHD), drug hypersensitivity syndrome (DIHS), or viral exanthema. These conditions often have overlapping clinical and laboratory presentations may be associated risk factors reactivation medications. In this study, we evaluated the incidence, present...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید